Linerixibat, CAS [[1345982-69-5]]

Produktübersicht

• Artikelname: Linerixibat, CAS [[1345982-69-5]]
• Artikelnummer: MCE-HY-16643
• Hersteller Artikelnummer: HY-16643
• Alternativnummer: MCE-HY-16643-5MG,MCE-HY-16643-10MMX1ML,MCE-HY-16643-50MG,MCE-HY-16643-25MG,MCE-HY-16643-1MG,MCE-HY-16643-100MG,MCE-HY-16643-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: GSK2330672

Produktbeschreibung

Linerixibat (GSK2330672) is a highly potent, nonabsorbable and orally active apical sodium-dependent bile acid transporter (ASBT) inhibitor with an IC50 of 42 nM human ASBT. Linerixibat can be used as lipid-lowering agent. Linerixibat has the potential for type 2 diabetes and Primary Biliary Cholangitis treatment[1][2][3].

Produkteigenschaften

• Molekulargewicht: 546.68
• Reinheit: 99.88
• CAS Nummer: [1345982-69-5]
• Formel: C28H38N2O7S
• Target-Kategorie: Apical Sodium-Dependent Bile Acid Transporter

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound